Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis

• Main Authors: Kate T Simms, DrPhD (Author), Jean-François Laprise, PhD (Author), Megan A Smith, MPH (Author), Jie-Bin Lew, MPH (Author), Michael Caruana, DPhil (Author), Marc Brisson, ProfPhD (Author), Karen Canfell, ProfDPhil (Author)
• Format: Book
• Published: Elsevier, 2016-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: First generation bivalent and quadrivalent human papillomavirus (HPV) vaccines have been introduced in most developed countries. A next generation nonavalent vaccine (HPV9) has become available, just as many countries are considering transitioning from cytology-based to HPV-base...